Livzon Pharmaceutical Group Inc. (SHE:000513)
China · Delayed Price · Currency is CNY 41.53
-0.73 (-1.73%)
Jul 18, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Chemical Agents | 6.57B | Log In | Log In | Log In | Log In | Upgrade |
Chemical Agents Growth | -6.13% | Log In | Log In | Log In | Log In | Upgrade |
APIs and Intermediates | 3.25B | Log In | Log In | Log In | Log In | Upgrade |
APIs and Intermediates Growth | 3.66% | Log In | Log In | Log In | Log In | Upgrade |
Traditional Chinese Medicine | 1.74B | Log In | Log In | Log In | Log In | Upgrade |
Traditional Chinese Medicine Growth | 39.19% | Log In | Log In | Log In | Log In | Upgrade |
Diagnostic Reagents and Equipment | 658.97M | Log In | Log In | Log In | Log In | Upgrade |
Diagnostic Reagents and Equipment Growth | -8.92% | Log In | Log In | Log In | Log In | Upgrade |
Biological | 84.43M | Log In | Log In | Log In | Log In | Upgrade |
Biological Growth | -79.33% | Log In | Log In | Log In | Log In | Upgrade |
Other Business | 49.45M | Log In | Log In | Log In | Log In | Upgrade |
Other Business Growth | 18.26% | Log In | Log In | Log In | Log In | Upgrade |
Sales Materials, Processing Fees, Etc. | 45.95M | Log In | Log In | Log In | Log In | Upgrade |
Rental | 9.06M | Log In | Log In | Log In | Log In | Upgrade |
Other | 13.67M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 96.17% | Log In | Log In | Log In | Log In | Upgrade |
Sales Materials | - | Log In | Log In | Log In | Log In | Upgrade |
Sales Materials Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Processing | - | Log In | Log In | Log In | Log In | Upgrade |
Processing Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Power Supply | - | Log In | Log In | Log In | Log In | Upgrade |
Power Supply Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Technology Transfer | - | Log In | Log In | Log In | Log In | Upgrade |
Western Drug Preparation Products - Gastrointestinal | - | Log In | Log In | Log In | Log In | Upgrade |
Western Drug Preparation Products - Gastrointestinal Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Bulk Medicines and Intermediates | - | Log In | Log In | Log In | Log In | Upgrade |
Bulk Medicines and Intermediates Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Western Drug Preparation Products - Gonadotropic Hormones | - | Log In | Log In | Log In | Log In | Upgrade |
Western Drug Preparation Products - Gonadotropic Hormones Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Western Drug Preparation Products - Antibiotics | - | Log In | Log In | Log In | Log In | Upgrade |
Western Drug Preparation Products - Antibiotics Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Western Drug Preparation Products - Others | - | Log In | Log In | Log In | Log In | Upgrade |
Western Drug Preparation Products - Others Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Western Drug Preparation Products - Cardio-cerebral Vascular | - | Log In | Log In | Log In | Log In | Upgrade |
Western Drug Preparation Products - Cardio-cerebral Vascular Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
China | 10.75B | Log In | Log In | Log In | Log In | Upgrade |
China Growth | -1.86% | Log In | Log In | Log In | Log In | Upgrade |
Overseas | 1.57B | Log In | Log In | Log In | Log In | Upgrade |
Overseas Growth | 0.40% | Log In | Log In | Log In | Log In | Upgrade |